(NASDAQ: PTN) Palatin Technologies's forecast annual revenue growth rate of -38.44% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.7%.
Palatin Technologies's revenue in 2026 is $12,884,261.On average, 4 Wall Street analysts forecast PTN's revenue for 2027 to be $20,965,197, with the lowest PTN revenue forecast at $17,436,895, and the highest PTN revenue forecast at $28,023,581.
In 2028, PTN is forecast to generate $8,686,421 in revenue, with the lowest revenue forecast at $4,359,224 and the highest revenue forecast at $11,209,433.